Stock News

12 Dividend Stocks to Build a Monthly Income Calendar
Johnson & Johnson loses pelvic mesh class action in Australia
US jury payouts leave insurers ‘facing $200bn hole’
Survey case studies: Gender on the agenda
No More Tears for Johnson & Johnson?
Buy Johnson & Johnson Stock, Analyst Says. The Pharma Giant Could Get Even Bigger.
J&J retests baby powder days after asbestos finding
Hedge Funds Open Kimono: 5 Best Healthcare Stocks To Buy

As seen on...